ConductScience.org, home

Paper36683074

Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.

Ai L and 33 others. Cell Discov, 2023. Cited by 119 papers, by iCite.

Cite this record

ConductScience Library. Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2. Papers, record 36683074. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36683074

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
PubMed
Journal
Cell Discov
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
119
iCite
Relative citation ratio, by iCite
11.8
iCite
Revised in PubMed
2023-02-01
PubMed

Authors34

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ai LLiangxia
2Li YYafei
3Zhou LLihttps://orcid.org/0000-0002-6736-0057
4Yao WWenrong
5Zhang HHao
6Hu ZZhaoyu
7Han JJinyu
8Wang WWeijie
9Wu JJunmiao
10Xu PPan
11Wang RRuiyue
12Li ZZhangyi
13Li ZZhouwang
14Wei CChengliang
15Liang JJianqun
16Chen HHaobo
17Yang ZZhimiao
18Guo MMing
19Huang ZZhixiang
20Wang XXin

Source PubMed

See all 34 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130154315Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging.Pharmaceutics2018https://conductscience.org/library/papers/30154315PubMed
218072597Long-term storage of DNA-free RNA for use in vaccine studies.Biotechniques2007https://conductscience.org/library/papers/18072597PubMed
323860045An efficient method for long-term room temperature storage of RNA.Eur J Hum Genet2014https://conductscience.org/library/papers/23860045PubMed
433400747Targeted liposomal drug delivery: a nanoscience and biophysical perspective.Nanoscale Horiz2021https://conductscience.org/library/papers/33400747PubMed
530898571Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments.Adv Drug Deliv Rev2019https://conductscience.org/library/papers/30898571PubMed
633321139Addressing the Cold Reality of mRNA Vaccine Stability.J Pharm Sci2021https://conductscience.org/library/papers/33321139PubMed
731629037Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide.J Control Release2019https://conductscience.org/library/papers/31629037PubMed
834417582The mutation that helps Delta spread like wildfire.Nature2021https://conductscience.org/library/papers/34417582PubMed
934995482mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.Cell2022https://conductscience.org/library/papers/34995482PubMed
1034131024SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques.Sci Immunol2021https://conductscience.org/library/papers/34131024PubMed
1134952914Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.Signal Transduct Target Ther2021https://conductscience.org/library/papers/34952914PubMed
1235131437Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine.Mol Ther2022https://conductscience.org/library/papers/35131437PubMed
1332206737Long-term storage of lipid-like nanoparticles for mRNA delivery.Bioact Mater2020https://conductscience.org/library/papers/32206737PubMed
1432978602Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay.Nat Protoc2020https://conductscience.org/library/papers/32978602PubMed
1534811367A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems.Nat Commun2021https://conductscience.org/library/papers/34811367PubMed
1635772405Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.Cell2022https://conductscience.org/library/papers/35772405PubMed
1717118485Freeze-drying of nanoparticles: formulation, process and storage considerations.Adv Drug Deliv Rev2006https://conductscience.org/library/papers/17118485PubMed
1832088327The challenge and prospect of mRNA therapeutics landscape.Biotechnol Adv2020https://conductscience.org/library/papers/32088327PubMed
1933839230mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability.Int J Pharm2021https://conductscience.org/library/papers/33839230PubMed
2034888894Omicron variant genome evolution and phylogenetics.J Med Virol2022https://conductscience.org/library/papers/34888894PubMed

See all 24 referencesDownload CSV of references

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.

PMIDTitleJournalYearIn PapersSource
42854694AI-integrated RNA therapeutics in precision oncology.Cell Rep Med2026https://conductscience.org/library/papers/42854694PubMed
42844249Bioengineering strategies for improving the immunogenicity of mRNA vaccines.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42844249PubMed
42806112Accelerated discovery of thermostable mRNA-lipid nanoparticle vaccines using data-efficient AI.Nat Biotechnol2026https://conductscience.org/library/papers/42806112PubMed
42804114mRNA lipid nanoparticle vaccines: current status, challenges and future prospects.Mol Biomed2026https://conductscience.org/library/papers/42804114PubMed
42729695In vivo immune cell engineering from bench to clinical reality.Pharm Sci Adv2026https://conductscience.org/library/papers/42729695PubMed
42717177Spray Freeze Drying for Solid Formulations of RNA Lipid Nanoparticles.AAPS PharmSciTech2026https://conductscience.org/library/papers/42717177PubMed
42711609An Investigation of Water Vapor Sorption for Improving Reconstitution Pathways of Freeze-Dried Lipid Nanoparticles Stabilized by Trehalose/Mannitol Excipients.AAPS PharmSciTech2026https://conductscience.org/library/papers/42711609PubMed
42654139Microneedles for Vaccination: Mechanistic Foundations, Materials Innovation, Clinical Translation, and Global Health Implementation.Pharmaceutics2026https://conductscience.org/library/papers/42654139PubMed
42654026Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges.Pharmaceutics2026https://conductscience.org/library/papers/42654026PubMed
42515660Chlorophyll-Loaded Castor Oil Nanoemulsions Exhibit Photodynamic Therapy Efficacy Against B16-F10 Melanoma with Low Cytotoxicity Toward HaCaT Keratinocytes.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515660PubMed
42514871Analytical Characterization and Stability Assessment of RNA-Based Vaccines.Pharmaceutics2026https://conductscience.org/library/papers/42514871PubMed
42353804Polymeric Delivery System for mRNA Therapeutics: Design Principles and Recent Advances.Genes (Basel)2026https://conductscience.org/library/papers/42353804PubMed
42253757Stabilization strategies and advancements in lyophilization to preserve integrity and efficacy of next-generation biologicals.Int J Pharm X2026https://conductscience.org/library/papers/42253757PubMed
42076139Industrial Perspective on the Manufacturing of Lipid Nanoparticles for Nucleic Acid Delivery.Pharmaceutics2026https://conductscience.org/library/papers/42076139PubMed
42039274Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution.Acta Pharm Sin B2026https://conductscience.org/library/papers/42039274PubMed
41942053Therapeutic peptides and proteins: Status and developments in drug delivery.J Control Release2026https://conductscience.org/library/papers/41942053PubMed
41893779Investigation on a Freeze-Drying Process for Long-Term Stability of mRNA-LNPs.Vaccines (Basel)2026https://conductscience.org/library/papers/41893779PubMed
41839853A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41839853PubMed
41814945A Cryoprotectant-Compatible Nanoporous Platform for Stable and Scalable Delivery of Biopharmaceuticals.Adv Mater2026https://conductscience.org/library/papers/41814945PubMed
41761431Drug Product Development of Lipid Nanoparticle-Based mRNA Therapeutics and Vaccines.Wiley Interdiscip Rev Nanomed Nanobiotechnol2026https://conductscience.org/library/papers/41761431PubMed

See all 86 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36683074

GET https://conductscience.org/api/papers/v1/36683074/authors?page=2